by Brooks | Dec 29, 2024 | Emerging Trends, PGx Clinical Practice
Husna Rahim, PharmD & Zachary S Brooks, PhD Integration of Pharmacogenomics in Clinical Practice. How soon can personalized medicine be part of mainstay healthcare? The evolution of PGx, or the study of how genes affect a person’s response to drugs, has...
by Brooks | Dec 29, 2024 | Emerging Trends, Research PGx
Jayden Lee, EMBA, PharmD, BCACP and Husna Rahim, PharmD Ethical Challenges in Pharmacogenomics Research. What are some key ethical issues in healthcare today? As the integration of genomic data into healthcare decisions becomes more widespread, it is vital to examine...
by Brooks | Dec 28, 2024 | Emerging Trends, Oncology-cancer
Husna Rahim, PharmD and Jennifer Tovar, PharmD Exploring the Impact of Pharmacogenomics on Cancer Treatment. What role does pharmacogenomics (PGx) play in shaping personalized cancer treatment plans? PGx examines how genetic differences impact drug response and...
by Brooks | Dec 28, 2024 | Drug Discovery, Emerging Trends
Jayden Lee, EMBA, PharmD, BCACP & Husna Rahim, PharmD Pharmacogenomics and Drug Development: Accelerating the Process Towards Precision Medicine. Will pharmacogenomic testing accelerate the development of new medications? With the rise of costs and risks of drug...
by Brooks | Dec 28, 2024 | Emerging Trends, Oncology-cancer
Zachary S. Brooks, PhD & Husna Rahim, PharmD Precision Oncology and Biomarker Tests: A New Era of Personalized Cancer Care. Is genomic medicine a viable option to advance cancer treatment in today’s data driven environment? By utilizing detailed biomarker...
by Brooks | Dec 28, 2024 | Emerging Trends, Inequities - Underrepresented
Jennifer Tovar, PharmD & Husna Rahim, PharmD Pharmacogenomics and Global Health Inequities: Bridging the Gap. How can pharmacogenomics (PGx) contribute to health equity on a global scale? Investing in PGx research in underrepresented populations can lead to...
